Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6UGN

Human Carbonic Anhydrase 2 complexed with SB4-205

Summary for 6UGN
Entry DOI10.2210/pdb6ugn/pdb
DescriptorCarbonic anhydrase 2, ZINC ION, 5,7-dimethyl-1lambda~6~,2,4-benzothiadiazine-1,1,3(2H,4H)-trione, ... (4 entities in total)
Functional Keywordscyclical sulfonamide, inhibitor, lyase, lyase-lyase inhibitor complex, lyase/lyase inhibitor
Biological sourceHomo sapiens
Total number of polymer chains1
Total formula weight29450.55
Authors
Murray, A.B.,Supuran, C.T.,McKenna, R. (deposition date: 2019-09-26, release date: 2019-12-18, Last modification date: 2023-10-11)
Primary citationBua, S.,Lomelino, C.,Murray, A.B.,Osman, S.M.,ALOthman, Z.A.,Bozdag, M.,Abdel-Aziz, H.A.,Eldehna, W.M.,McKenna, R.,Nocentini, A.,Supuran, C.T.
"A Sweet Combination": Developing Saccharin and Acesulfame K Structures for Selectively Targeting the Tumor-Associated Carbonic Anhydrases IX and XII.
J.Med.Chem., 63:321-333, 2020
Cited by
PubMed Abstract: The sweeteners saccharin () and acesulfame K () recently entered the topic of anticancer human carbonic anhydrase (CA, EC 4.2.1.1) inhibitors, as they showed to selectively inhibit the tumor-associated CAs IX/XII over ubiquitous CAs. A drug design strategy is here reported, which took and as leads and produced a series of 2-benzo[][1,2,4]thiadiazin-3(4)-one-1,1-dioxides (). Many derivatives showed greater potency (s-CA IX 19.1-408.5 nM) and selectivity (II/IX SI 2-76) than the leads (s-CA IX 103, 2400 nM; II/IX-SI 56, >4) against CA IX/XII over off-target isoforms. A thorough X-ray crystallographic study depicted their binding mode to both CA II and IX-mimic. The most representative were characterized in vitro for their antitumor activity against A549, PC-3, and HCT-116 cancer cell lines both in normoxia and hypoxia. The two most effective compounds were assayed for their effect on several apoptosis markers, identifying promising leads for the development of new anticancer drugs.
PubMed: 31794211
DOI: 10.1021/acs.jmedchem.9b01669
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.406 Å)
Structure validation

237423

数据于2025-06-11公开中

PDB statisticsPDBj update infoContact PDBjnumon